SCHEMBL25318449

SCHEMBL25318449

CC(C)(C)OC(=O)C(Cc1cccc(F)c1)N=C(c1ccccc1)c1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AAK1 Q2M2I8 1/20 0.61
CTSS P25774 1/20 0.47
CTSK P43235 1/20 0.47
SLC7A5 Q01650 1/20 0.45
PPARG P37231 3/20 0.43
PPARA Q07869 2/20 0.43
SLC1A1 P43005 2/20 0.41
JAK2 O60674 1/20 0.40
ALDH1A1 P00352 1/20 0.40
TP53 P04637 1/20 0.40
HPGD P15428 1/20 0.40
MAPK1 P28482 1/20 0.40
HTT P42858 1/20 0.40
ATM Q13315 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
HSD17B10 Q99714 1/20 0.40
KDM4E B2RXH2 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
MAPT P10636 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL548007 0.88 AAK1 (0.68) AAK1CTSSCTSKSLC7A5PPARG
SCHEMBL3219664 0.88 AAK1 (0.68) AAK1CTSSCTSKSLC7A5PPARG
SCHEMBL548006 0.88 AAK1 (0.68) AAK1CTSSCTSKSLC7A5PPARG
SCHEMBL22033066 0.87 AAK1 (0.59) AAK1CTSSCTSKSLC7A5ITGA4
SCHEMBL18511393 0.87 AAK1 (0.65) AAK1CTSSCTSKSLC7A5PPARG
SCHEMBL18511387 0.86 AAK1 (0.61) AAK1CTSSCTSKSLC7A5PPARG
SCHEMBL21029344 0.84 AAK1 (0.58) AAK1CTSSCTSKSLC7A5ITGA4
SCHEMBL21029145 0.84 AAK1 (0.58) AAK1CTSSCTSKSLC7A5PPARG
SCHEMBL3750184 0.84 AAK1 (0.58) AAK1CTSSCTSKSLC7A5PPARG
SCHEMBL3750181 0.84 AAK1 (0.58) AAK1CTSSCTSKSLC7A5PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116348109-B Piperazine derivative, and preparation method and application thereof 浙江海正药业股份有限公司 2025-01-21 CN disclosed
US-20230373972-A1 PIPERAZINE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. (CN) 2023-11-23 US disclosed
US-20230373972-A1 PIPERAZINE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. (CN) 2023-11-23 US disclosed
US-20230373972-A1 PIPERAZINE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. (CN) 2023-11-23 US disclosed
EP-4215525-A1 PIPERAZINE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF Zhejiang Hisun Pharmaceutical Co., Ltd. (CN) 2023-07-26 EP disclosed
EP-4215525-A1 PIPERAZINE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF Zhejiang Hisun Pharmaceutical Co., Ltd. (CN) 2023-07-26 EP disclosed
CN-116348109-A Piperazine derivative, and preparation method and application thereof 浙江海正药业股份有限公司 2023-06-27 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230373972-A1 PIPERAZINE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF F7, F11, HABP2 AAK1 4223/4885CTSS 644/4885CTSK 1492/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.